Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorPrograma d'Harmonització Farmacoterapèutica
dc.date.accessioned2021-11-11T12:59:23Z
dc.date.available2021-11-11T12:59:23Z
dc.date.issued2018-09-01
dc.identifier.citationPrograma d'Harmonització Farmacoterapèutica. Tractament farmacològic de la malaltia d’Alzheimer: informe d’avaluació de resultats del Registre de tractament farmacològic de la malaltia d’Alzheimer. Barcelona: Servei Català de la Salut; 2018.
dc.identifier.urihttp://hdl.handle.net/11351/6533
dc.descriptionAlzheimer; Pharmacological treatment; Pharmacological treatment of Alzheimer's disease
dc.description.abstractThe Register of Pharmacological Treatment of Alzheimer’s Disease (RTFMA) for people diagnosed with Alzheimer’s Disease (AD), implemented in 2011, is a computer application linked to the Integrated Electronic Prescription System (SIRE). The RTFMA is used for the automatic validation of the dispensing of treatments for the Alzheimer’s disease. Personal, clinical, and treatment data prescribed to patients should be included as a necessary condition for the validation and dispensing of drugs at the start of treatment. The validity of the treatment lasts 24 months, and then it is necessary to request its renewal. The results are collected using the global deterioration scale (GDS-FAST, possible values ​​between 1 and 7 where 7 is the worst deterioration; within 6 there are 5 degrees of severity ranging from A to E, and within the 7 six more degrees ranging from A to F). The Minimental test (Mini-Mental State Examination [MMSE], values ​​between 0 and 30, where the lowest values ​​indicate the worst deterioration) is also included, although for simplicity they are not included in this summary. The RTFMA contains relative information on prescriptions for acetylcholinesterase inhibitor (IACE) drugs and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists since 2012.
dc.language.isocat
dc.publisherServei Català de la Salut
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectRegistres mèdics
dc.subjectAlzehimer, Malaltia d' - Tractament
dc.subjectMedicaments - Prescripció
dc.subject.meshAlzheimer Disease
dc.subject.meshMedical Records
dc.subject.meshDrug Therapy
dc.titleTractament farmacològic de la malaltia d’Alzheimer: informe d’avaluació de resultats del Registre de tractament farmacològic de la malaltia d’Alzheimer
dc.typeinfo:eu-repo/semantics/report
dc.subject.decsenfermedad de Alzheimer
dc.subject.decsregistros médicos
dc.subject.decsfarmacoterapia
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record